<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03364140</url>
  </required_header>
  <id_info>
    <org_study_id>TKD-PPKM</org_study_id>
    <nct_id>NCT03364140</nct_id>
  </id_info>
  <brief_title>A Registry of Peripartum Cardiomyopathy in Turkey</brief_title>
  <official_title>Clinical A Nation-wide Registry of Peripartum Cardiomyopathy: Clinical Status in Turkey</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ege University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Turkish Society of Cardiology</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Ege University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Peripartum cardiomyopathy (PPCM) is a global disease with significant morbidity and mortality
      of young women. Its' etiology, epidemiology and treatment is not yet well described. This
      will be a retrospective, national, multicenter observational study, conducted in Turkey. It
      is expected that approximately 50 women with PPCM will be recorded.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Peripartum cardiomyopathy (PPCM) is a global disease with significant morbidity and mortality
      of young women. Its' etiology, epidemiology and treatment is not yet well described. This
      will be a retrospective, national, multicenter observational study, conducted in centres in
      Turkey. It is expected that approximately 50 women with PPCM will be recorded.

      The objectives of the study are:

      To define the clinical status and clinical characteristics of PPCM in Turkey

      To define the outcome of PPCM (short and long term)

      To define the demographical and possible etiological factors

      To define prognostic factors
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 2, 2017</start_date>
  <completion_date type="Anticipated">January 15, 2018</completion_date>
  <primary_completion_date type="Anticipated">January 15, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Pregnancy outcome</measure>
    <time_frame>5 months after delivery</time_frame>
    <description>mortality of the mother</description>
  </primary_outcome>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Peripartum Cardiomyopathy</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Female patients with unexplained Heart Failure symptoms developed towards the end of
        pregnancy or in the first 6 months of postpartum period
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient above 18 years of age

          -  Unexplained Heart Failure symptoms developed towards the end of pregnancy or in the
             first 6 months of postpartum period

          -  Ejection fraction less than 45% documented with echocardiography

        Exclusion Criteria:

          -  Patients with any other known cardiac pathology
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Female aged &gt;18 years</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dilek Ural, MD</last_name>
    <role>Study Director</role>
    <affiliation>Koc University Medical school</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Meral Kayikcioglu, MD</last_name>
    <phone>+902323905448</phone>
    <email>meral.kayikcioglu@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Meral Kayikcioglu</last_name>
    <phone>+902323905448</phone>
    <email>meral.kayikcioglu@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Koc University Medical School Cardiology Department</name>
      <address>
        <city>Istanbul</city>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dilek Ural, MD</last_name>
      <email>duralk@tkd.org.tr</email>
    </contact>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 9, 2017</study_first_submitted>
  <study_first_submitted_qc>December 4, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">December 6, 2017</study_first_posted>
  <last_update_submitted>December 4, 2017</last_update_submitted>
  <last_update_submitted_qc>December 4, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 6, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ege University</investigator_affiliation>
    <investigator_full_name>Meral Kayikcioglu</investigator_full_name>
    <investigator_title>Prof Dr</investigator_title>
  </responsible_party>
  <keyword>Peripartum Cardiomyopathy</keyword>
  <keyword>Heart Failure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiomyopathies</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

